SOUTHLAKE, Texas, June 11, 2026 (GLOBE NEWSWIRE) — American Fusion™ Inc. (OTC: AMFN) (“American Fusion™” or the “Company”), a company developing advanced fusion energy technologies, including its Texatron™ Fusion Engine™ platform, announced the filing of an additional patent application as the Company continues to expand its intellectual property portfolio and advance development of future generations of the Texatron™ Fusion Engine™.
The Company’s newest patent filing, U.S. Patent Application No. 19/701,742, was filed on June 10, 2026 and relates to a novel fusion system architecture incorporating advanced housing and chamber design elements intended to support plasma confinement, pulsed energy delivery, and future commercial deployment of the Texatron™ Fusion Engine™ platform.
Management believes the application represents another important building block in the Company’s long-term intellectual property strategy and further demonstrates the Company’s commitment to protecting innovations developed through the ongoing evolution of the Texatron™ Fusion Engine™ platform.
American Fusion™’s intellectual property program continues to expand as the Company advances toward commercialization of its compact aneutronic fusion technology. Management believes the technologies embodied within Patent Application No. 19/701,742 may serve as the foundation for numerous future patent filings covering reactor geometries, confinement methodologies, pulsed power delivery systems, plasma control techniques, and commercial deployment architectures.
“The filing of Patent Application No. 19/701,742 represents another important step in the continued development of our intellectual property portfolio,” said Michael Smith, Chief Legal Officer of American Fusion™. “As we advance the Texatron™ Fusion Engine™ platform, we remain focused on protecting innovations that may support future product development, commercialization initiatives, and long-term competitive differentiation.”
The Company continues to advance development activities associated with its 5MW Pre-Production Texatron™ Fusion Engine™ program.
American Fusion™ submitted its application for certification and related approvals to the Texas Department of State Health Services (“DSHS”) on February 27, 2026. The Company continues to work with DSHS regarding licensing and certification requirements associated with its planned testing activities and remains encouraged by the progress achieved to date.
Management also reports continued progress on several development initiatives, including:
The Company recently announced that final modifications to its 5MW Pre-Production Texatron™ Fusion Engine™ are nearing completion at the fabrication facility of a third-party manufacturing partner in Midland/Odessa, Texas. Management currently expects to take delivery of the system in the near term as preparations continue for future testing activities in the Dallas-Fort Worth Metroplex.
American Fusion™ also announced that Executive Chairman Brent Nelson recently participated in an exclusive interview with Dave Donlin of Small Cap Stocks Today. During the discussion, Mr. Nelson provided updates regarding the Company’s intellectual property strategy, regulatory progress, development of the Texatron™ Fusion Engine™ platform, planned testing initiatives, and long-term commercialization objectives.
The interview is currently available through the Small Cap Stocks Today Podcast on multiple platforms, including:
Management believes direct engagement with shareholders, investors, and the broader investment community remains an important component of the Company’s commitment to transparency and regular communication.
“Intellectual property development, regulatory advancement, and execution of our testing roadmap remain core priorities for the Company,” said Brent Nelson, Executive Chairman of American Fusion™. “We believe each additional patent filing strengthens the foundation of the Texatron™ Fusion Engine™ platform while supporting our broader commercialization strategy. At the same time, we continue advancing toward important testing and validation milestones that we believe will help define the next stage of the Company’s development.”
American Fusion™ believes that the combination of continued intellectual property expansion, regulatory progress, development of its testing infrastructure, and advancement of its pre-production systems positions the Company for an important period of growth as it pursues commercialization of its proprietary aneutronic fusion technology.
Management remains focused on executing its development roadmap while continuing to build long-term value through innovation, strategic intellectual property protection, disciplined engineering, and advancement toward commercial deployment.
American Fusion™ Inc.
Administration Mailing Address:
401 N Carroll Ave., Ste. 192
Southlake, TX 76092
United States
